These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
178 related items for PubMed ID: 6473507
1. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats with a portacaval shunt. van der Graaff M, Vermeulen NP, Joeres RP, Breimer DD. Pharmacology; 1984; 29(2):99-109. PubMed ID: 6473507 [Abstract] [Full Text] [Related]
2. Correlation between the in vivo metabolism of hexobarbital and antipyrine in rats. van der Graaff M, Vermeulen NP, Joeres RP, Vlietstra T, Breimer DD. J Pharmacol Exp Ther; 1983 Nov; 227(2):459-65. PubMed ID: 6631725 [Abstract] [Full Text] [Related]
5. Relationship between the metabolism of antipyrine, hexobarbital and theophylline in patients with liver disease as assessed by a 'cocktail' approach. Schellens JH, Janssens AR, van der Wart JH, van der Velde EA, Breimer DD. Eur J Clin Invest; 1989 Oct; 19(5):472-9. PubMed ID: 2511024 [Abstract] [Full Text] [Related]
6. Disposition of allylic oxidation pathway metabolites of racemic hexobarbital in the rat. Van der Graaff M, Vermeulen NP, Vinks MH, Breimer DD. Eur J Drug Metab Pharmacokinet; 1986 Oct; 11(2):107-11. PubMed ID: 3770011 [Abstract] [Full Text] [Related]
10. Influence of rifampicin on drug metabolism: differences between hexobarbital and antipyrine. Breimer DD, Zilly W, Richter E. Clin Pharmacol Ther; 1977 Apr; 21(4):470-81. PubMed ID: 849678 [Abstract] [Full Text] [Related]
11. [Hexobarbital-oxidation in vivo and in vitro in rats after phenobarbital-pretreatment or after portacaval anastomosis (author's transl)]. Richter E, Gallenkamp H, Brachtel D, GrĂ¼n M. Z Gastroenterol; 1977 Jun; 15(6):389-92. PubMed ID: 888489 [Abstract] [Full Text] [Related]
12. Influence of allylisopropylacetamide and phenobarbital treatment on in vivo antipyrine metabolite formation in rats. Teunissen MW, Van Graft M, Vermeulen NP, Breimer DD. Xenobiotica; 1983 Aug; 13(8):497-502. PubMed ID: 6649682 [Abstract] [Full Text] [Related]
14. Antipyrine metabolism is not affected by terbinafine, a new antifungal agent. Seyffer R, Eichelbaum M, Jensen JC, Klotz U. Eur J Clin Pharmacol; 1989 Aug; 37(3):231-3. PubMed ID: 2612536 [Abstract] [Full Text] [Related]
16. Antipyrine as a probe for human oxidative drug metabolism: identification of the cytochrome P450 enzymes catalyzing 4-hydroxyantipyrine, 3-hydroxymethylantipyrine, and norantipyrine formation. Engel G, Hofmann U, Heidemann H, Cosme J, Eichelbaum M. Clin Pharmacol Ther; 1996 Jun; 59(6):613-23. PubMed ID: 8681486 [Abstract] [Full Text] [Related]
17. Effects of urea on hexobarbital and antipyrine disposition in rats. Valentovic M, Bachmann K. Pharmacology; 1980 Jun; 21(3):167-74. PubMed ID: 7413718 [Abstract] [Full Text] [Related]
18. Influence of 9-hydroxyellipticine and 3-methylcholanthrene treatment on antipyrine metabolite formation in rats in vivo. Teunissen MW, Joeres RP, Vermeulen NP, Breimer DD. Xenobiotica; 1983 Apr; 13(4):223-31. PubMed ID: 6624137 [Abstract] [Full Text] [Related]
20. Pharmacokinetics of simultaneously administered hexobarbital and heptabarbital in rats: an alternative approach to metabolic correlation studies. van der Graaff M, Vermeulen NP, Langendijk PN, Breimer DD. J Pharmacol Exp Ther; 1983 Jun; 225(3):747-51. PubMed ID: 6134816 [Abstract] [Full Text] [Related] Page: [Next] [New Search]